Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1875 of 3173 entries
View as:

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04668066 Org: User:
Start: 12/10/20 End: 12/27/22 Due: 12/27/23

A Study Of PF-06263507 In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01891669 Org: User:
Start: 08/08/13 End: 06/29/15 Due: 06/29/16

This Study Will Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01258751 Org: User:
Start: 12/31/10 End: 05/31/11 Due: 05/31/12

Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030)

Phase: N/A Priority: Normal
NCT ID: NCT01840319 Org: User:
Start: 02/28/13 End: 07/31/13 Due: 07/31/14

Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults

Phase: N/A Priority: Normal
NCT ID: NCT04882085 Org: User:
Start: 08/26/21 End: 08/31/23 Due: 08/31/24

AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00071006 Org: User:
Start: 09/30/03 End: 07/31/04 Due: 07/31/05

Study Of Single Doses Of PF-06291826 (Tafamidis) In Japanese And Western Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01369836 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients

Phase: N/A Priority: Normal
NCT ID: NCT04828993 Org: User:
Start: 04/28/21 End: 02/12/23 Due: 02/12/24

A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00991159 Org: User:
Start: 11/30/09 End: 05/31/10 Due: 05/31/11

A Phase I, Healthy Volunteer Positron Emission Tomography Study

Phase: N/A Priority: Normal
NCT ID: NCT00730990 Org: User:
Start: 05/31/08 End: 11/30/08 Due: 11/30/09

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Phase: N/A Priority: Normal
NCT ID: NCT00161967 Org: User:
Start: 05/31/05 End: 11/30/08 Due: 11/30/09

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT00038311 Org: User:
Start: 09/30/00 End: 03/31/03 Due: 03/31/04

Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00793546 Org: User:
Start: 02/28/09 End: 06/30/10 Due: 06/30/11

Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)

Phase: N/A Priority: Normal
NCT ID: NCT02655419 Org: User:
Start: 05/19/16 End: 10/26/17 Due: 10/26/18

A Study Of Tasocitinib In Dry Eye Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01226680 Org: User:
Start: 12/01/10 End: 10/19/12 Due: 10/19/13

Pegvisomant And Sandostatin LAR Combination Study

Phase: N/A Priority: Normal
NCT ID: NCT00068029 Org: User:
Start: 10/31/03 End: 05/31/06 Due: 05/31/07

Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00556257 Org: User:
Start: 08/31/07 End: - Due: -

A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00938587 Org: User:
Start: 10/07/09 End: 07/29/10 Due: 07/29/11

This Study Is To Estimate The Time Course Of Pf-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

Phase: N/A Priority: Normal
NCT ID: NCT01272375 Org: User:
Start: 01/31/11 End: 05/31/11 Due: 05/31/12

Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis

Phase: N/A Priority: Normal
NCT ID: NCT04399538 Org: User:
Start: 08/10/20 End: 04/28/22 Due: 04/28/23

A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02855177 Org: User:
Start: 08/24/16 End: 04/12/17 Due: 04/12/18

A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in Australia

Phase: N/A Priority: Normal
NCT ID: NCT06624020 Org: User:
Start: 05/20/24 End: 07/31/24 Due: 07/31/25

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03796676 Org: User:
Start: 02/18/19 End: 04/08/20 Due: 04/08/21

A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03077607 Org: User:
Start: 11/07/16 End: 01/20/18 Due: 01/20/19

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01923389 Org: User:
Start: 09/30/13 End: 12/31/13 Due: 12/31/14